HOME >> BIOLOGY >> NEWS
Pomegranate juice slows PSA acceleration rate after prostate cancer surgery, radiation

PHILADELPHIA Pomegranate juice packs a punch on prostate cancer that prolongs post-surgery PSA doubling time, drives down cancer cell proliferation and causes prostate cancer cells to die, according to a study published in the July 1 issue of Clinical Cancer Research.

Researchers at the Jonsson Cancer Center at UCLA reported that patients with recurrent prostate cancer who drank pomegranate after surgery or radiation treatment saw their PSA blood content levels double after about 54 months. By comparison, PSA levels in the same patients prior to drinking the daily doses of eight-ounce pomegranate juice accelerated more quickly, doubling their PSA levels in only 15 months.

PSA, or prostate specific antigen, is a protein marker for prostate cancer. The faster PSA levels increase in the blood of men after treatment, the greater their potential for dying of prostate cancer.

"The velocity of the increase in PSA is decreased by 35 percent among those who drank the pomegranate juice," said Allan Pantuck, M.D., associate professor, Department of Urology, David Geffen School of Medicine, UCLA, and lead author of the paper.

"We are hoping that pomegranate juice offers a novel strategy for prolonging the doubling time in men who have been treated for prostate cancer," Dr. Pantuck added.

According to the study, sera from patients after treatment yielded a net decrease of almost 30 percent in the numbers of prostate cancer cells raised in culture. Similarly, cultured sera from these patients decreased cell proliferation by 12 percent, compared to cells grown with sera from the men taken prior to initiation of the pomegranate treatment program. In addition, treated sera induced 17 percent more programmed cell death, or apoptosis, than sera from the men prior to treatment.

Additional exploratory experiments conducted by Dr. Pantuck and his colleagues examined antioxidant characteristics of the fruit juice. '"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
1-Jul-2006


Page: 1 2

Related biology news :

1. Pomegranate juice helps keep PSA levels stable in men with prostate cancer
2. Pomegranate juice for moms may help babies resist brain injury
3. New study suggests Concord grape juice may provide protection against breast cancer
4. 100 percent juice not associated with overweight in children
5. Cloudy apple juice four times healthier than clear
6. Pediatrics study shows no link between juice and childrens weight
7. Orange juice beverage fortified with plant sterols lowers indicators of heart disease risk
8. Fruit juice intake among preschool children not associated with weight
9. Compounds in cranberry juice show promise as alternatives to antibiotics
10. Study shows fruit and vegetable juice consumption may reduce risk of Alzheimers disease
11. UMass Lowell research shows benefits of apple juice on neurotransmitter affecting memory

Post Your Comments:
(Date:11/11/2014)... Nov. 11, 2014  Forensicon, Inc., a ... pleased to announce the promotion of Yaniv Schiff ... Digital Forensics. In Schiff,s new role as Director, he ... of digital forensics examiners and provide leadership within the ... - http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined ...
(Date:11/6/2014)... TALLAHASSEE, Fla. -- A groundbreaking paper from a team ... better understanding of how plants could adapt to and ... The research, published in the latest issue of the ... how chromatin (the complex of DNA and proteins) is ... material, so that some genes are turned on and ...
(Date:11/5/2014)... Redmond has dedicated his career to understanding the ... general audience. , As deputy director and regional ... Nevada,s Desert Research Institute, Redmond has more than ... and dissemination of climate data to the general ... in San Francisco on December 15-19, 2014 the ...
Breaking Biology News(10 mins):Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Maize analysis yields whole new world of genetic science 2Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2
(Date:11/15/2014)... -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH ), ... third quarter ended September 30, 2014. ... 2014 was $7.0 million, compared to $5.8 million for ... loss is mainly driven by higher research and development ... both our Phase 3 systemic lupus erythematosus clinical study, ...
(Date:11/12/2014)... The “Pen Needles Market by by Needle ... (Insulin, Growth Hormones, Glucagon-like peptide) & by Type (Standard ... 2019”analyzes and studies the major market drivers, threats, opportunities, ... and 51 figures spread through 185 pages and in-depth ... Safety), by Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, ...
(Date:11/12/2014)...  ReachBio Research Labs (a registered trade name of ... today that it has signed an agreement with Funakoshi ... Funakoshi non-exclusive distribution rights to ReachBio,s human primary cell ... Japan . Under a companion agreement, ... to Japanese drug development companies. Photo - ...
(Date:11/12/2014)... November 11, 2014 The new ... Imaging, Ultrasound (Color Doppler, Portable), Magnetic Resonance Imaging, ... SPECT) - Emerging Markets (BRIC - Brazil, Russia, ... to 2011-2018”, analyzes and studies the major market ... India, and China. , Browse 103 market ...
Breaking Biology Technology:Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 5Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 6Pen Needles Market worth $2,105 Million by 2019 - New Report by MarketsandMarkets 2Pen Needles Market worth $2,105 Million by 2019 - New Report by MarketsandMarkets 3Pen Needles Market worth $2,105 Million by 2019 - New Report by MarketsandMarkets 4Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 3BRIC Diagnostic Imaging Equipment Market Worth $7.6 Billion by 2018 - New Report by MarketsandMarkets 2BRIC Diagnostic Imaging Equipment Market Worth $7.6 Billion by 2018 - New Report by MarketsandMarkets 3BRIC Diagnostic Imaging Equipment Market Worth $7.6 Billion by 2018 - New Report by MarketsandMarkets 4BRIC Diagnostic Imaging Equipment Market Worth $7.6 Billion by 2018 - New Report by MarketsandMarkets 5
Cached News: